‘We’ve Got The Broadest Pure-Play Oncology Portfolio In The industry’ – Pfizer Talks Biosimilars

Pfizer’s Supportive Care Oncology Commercial Lead Discusses The Firm’s Biosimilars Business

 
• By David Wallace
  
Pfizer new logo
Pfizer executive Barry Chester talks to Generics Bulletin
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products